anthralin has been researched along with Eosinophilia in 1 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malisiewicz, B | 1 |
| Murer, C | 1 |
| Pachlopnik Schmid, J | 1 |
| French, LE | 1 |
| Schmid-Grendelmeier, P | 1 |
| Navarini, AA | 1 |
1 other study available for anthralin and Eosinophilia
| Article | Year |
|---|---|
Eosinophilia during psoriasis treatment with TNF antagonists.
Topics: Adalimumab; Anthralin; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Therapy, Combina | 2011 |